Foley & Lardner LLP represented global private equity health care specialist ARCHIMED in its acquisition…
Thomas CarlucciApril 11, 2024
Foley & Larder LLP represented TCG Crossover (“TCGX”) as the lead investor in the $127.5…
Louis LehotFebruary 13, 2024
Foley & Larder LLP represented TCG Crossover (“TCGX”) as an investor in the $120 million…
Louis LehotFebruary 13, 2024
Foley & Larder LLP recently represented TCG Crossover (“TCGX”) as a lead investor in the…
Louis LehotFebruary 13, 2024
Foley & Lardner LLP represented TCGX as an investor in the $75 million private placement…
Louis LehotJanuary 24, 2024
Foley & Lardner LLP represented TCGX as co-lead investor in the $150 million Series B…
Louis LehotJanuary 23, 2024
Foley & Lardner LLP recently represented New Enterprise Associates, Inc. (NEA) as lead investor in…
Louis LehotJanuary 18, 2024
Foley & Lardner LLP served as legal adviser to knownwell, an in-person and virtual weight-inclusive…
Von BryantDecember 21, 2023
With the Health Care & Life Sciences sector under pressure to improve patient outcomes while…
Foley IgniteDecember 11, 2023